Skip to content
Assyro AI

Title f-27 LAWS reference

Explore the full hierarchy of this title across chapters, subchapters, and parts.

Select a part from the tree to begin

Browse chapters and parts on the left to load sections

CANADA • Title f-27 Laws • Part 12

Part 12 — Drugs not to be sold unless safe manufacture indicated

This section prohibits the sale of drugs listed in Schedule C or D unless the Minister has confirmed that the manufacturing premises, process, and conditions are suitable to ensure the drug's safety for use.

What this part covers

  • No person shall sell any drug described in Schedule C or D unless the Minister has indicated suitability.
  • The Minister's indication must confirm that the manufacturing premises, process, and conditions are suitable.
  • The suitability must ensure that the drug will not be unsafe for use.

Sections in Part 12

§ 12

Drugs not to be sold unless safe manufacture indicated

Regulatory Context

This document sits within CANADA Laws and is most useful when linked to operational submission, quality, and inspection workflows.

CANADALaws

Related Terms

Operational Use Cases

Related Actions